NCT06543771View on ClinicalTrials.gov

Clinical Performance Study of Safety Test ABO Device

NANot yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Transfusion Reaction
Interventions
DIAGNOSTIC_TEST

Safety Test ABO and ABTest Card®

Pre transfusional control with the Safety Test ABO device (reference device) and the ABTest Card® device (comparator).

Trial Locations (1)

Unknown

CHU Montpellier, Montpellier

Sponsors

Lead Sponsor

Diagast

Collaborators (1)

Soladis
All Listed Sponsors
collaborator

Soladis

INDUSTRY

lead

Diagast

INDUSTRY

NCT06543771 - Clinical Performance Study of Safety Test ABO Device | Biotech Hunter | Biotech Hunter